Lockheed Martin: A Top Defense Pick After Q2 Earnings

Lockheed Martin reported Q2 sales up 11% YoY, indicating accelerating demand alongside effective capacity expansion. The company raised full-year guidance to 8% sales growth and kept segment operating margin around 10.7%. Backlog hit $230B with a 3.2x book-to-bill ratio, reinforcing strong demand and revenue visibility.

Analysis

The market implication is less about one quarter’s revenue beat and more about evidence that LMT can actually convert backlog into throughput without a margin collapse. That matters because defense primes are usually valued on program execution credibility; if investors believe the capacity ramp is real, the multiple can expand relative to peers that are still hostage to delivery slippage. The second-order winner is likely the industrial supply chain tied to missile, electronics, and avionics content, where a sustained build rate can finally support volume leverage after two years of inventory uncertainty.

The risk is that the story shifts from “demand is strong” to “working capital is the bottleneck.” In the next 1-2 quarters, the stock could give back gains if cash conversion lags, if the margin profile is preserved only by mix rather than pricing power, or if contract timing gets pushed by budget continuing resolutions. The 6-18 month thesis remains intact only if LMT keeps converting backlog into revenue faster than its peers; otherwise, this becomes a low-growth, high-visibility name that deserves only a modest premium.

Contrarian view: the consensus may be underestimating how much of the good news is already embedded in defense shares broadly. If the incremental evidence is simply “the backlog is real,” then the upside may be more relative than absolute, favoring stock selection over sector beta. The cleanest expression is to own LMT against a defense basket rather than chase the whole group, because the main catalyst is execution differentiation, not a change in the defense spending cycle.

Key Decisions for Investors

• Buy LMT on a pullback over the next 1-2 sessions; use the post-print gap as support and look for 8-12% upside over 1-3 months if margins hold and management reiterates guide.
• Pair trade: long LMT / short XAR for 1-3 months to isolate execution alpha from defense-sector beta; thesis fails if the broader defense tape re-rates faster than LMT on budget headlines.
• Set a watch item on LMT free-cash-flow conversion and working-capital swing at the next print; if cash burn widens while sales accelerate, fade the rally.
• For options, consider a 3-6 month LMT call spread only if implied vol remains below the stock’s historical post-earnings move; avoid naked calls if supply-chain execution risk remains elevated.
• Relative-value alert: if NOC/RTX outperform LMT after this print without a corresponding guidance revision, the market is likely paying up for easier consensus beats rather than true operational improvement.